{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:51:32Z","timestamp":1790898692656,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BE6555\/1-1"],"award-info":[{"award-number":["BE6555\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BE6555\/2\u20131"],"award-info":[{"award-number":["BE6555\/2\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005677","name":"Jos\u00e9 Carreras Leuk\u00e4mie-Stiftung","doi-asserted-by":"publisher","award":["DJCLS 16R\/2021"],"award-info":[{"award-number":["DJCLS 16R\/2021"]}],"id":[{"id":"10.13039\/501100005677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.beha.2023.101511","type":"journal-article","created":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T21:05:46Z","timestamp":1692219946000},"page":"101511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cytogenetics and genomics in pediatric acute lymphoblastic leukaemia"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9398-2637","authenticated-orcid":false,"given":"\u017deljko","family":"Anti\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Lentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke K.","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2023.101511_bib1","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2023.101511_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.6004\/jnccn.2020.0001","article-title":"Pediatric acute lymphoblastic leukemia, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Brown","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.beha.2023.101511_bib3","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.beha.2023.101511_bib4","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1200\/JCO.2015.64.6364","article-title":"Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: study ALL10 from the Dutch childhood oncology group","volume":"34","author":"Pieters","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2023.101511_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/j.seminhematol.2013.06.007","article-title":"A 50-year journey to cure childhood acute lymphoblastic leukemia","volume":"50","author":"Pui","year":"2013","journal-title":"Semin Hematol"},{"key":"10.1016\/j.beha.2023.101511_bib6","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2023.101511_bib7","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1200\/JCO.19.01692","article-title":"Improved CNS control of childhood acute lymphoblastic leukemia without cranial irradiation: st Jude total therapy study 16","volume":"37","author":"Jeha","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2023.101511_bib8","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1182\/blood-2015-09-670729","article-title":"Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000","volume":"127","author":"M\u00f6ricke","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(14)70243-8","article-title":"Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial","volume":"15","author":"Vora","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beha.2023.101511_bib10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/leu.2017.265","article-title":"Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia","volume":"32","author":"Toft","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101511_bib11","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.19.01086","article-title":"Outcome in children with standard-risk B-cell acute lymphoblastic leukemia: results of children's oncology group trial AALL0331","volume":"38","author":"Maloney","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2023.101511_bib12","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1200\/JCO.2015.62.4544","article-title":"Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-acute lymphoblastic leukemia: a report from children's oncology group study AALL0232","volume":"34","author":"Larsen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2023.101511_bib13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.beha.2005.11.003","article-title":"History of the treatment of childhood ALL: a paradigm for cancer cure","volume":"19","author":"Simone","year":"2006","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.beha.2023.101511_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.V37.1.59.59","article-title":"Variation in survival among patients with acute lymphocytic leukemia","volume":"37","author":"Zippin","year":"1971","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib15","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.2820360926","article-title":"Initial features and prognosis in 363 children with acute lymphocytic leukemia","volume":"36","author":"Simone","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.beha.2023.101511_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1182\/blood.V36.3.353.353","article-title":"Brief report: Philadelphia chromosome in acute lymphocytic leukemia","volume":"36","author":"Propp","year":"1970","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib17","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/bmj.2.6151.1529","article-title":"Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis","volume":"2","author":"Secker-Walker","year":"1978","journal-title":"Br Med J"},{"key":"10.1016\/j.beha.2023.101511_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","article-title":"Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling","volume":"1","author":"Yeoh","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beha.2023.101511_bib19","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.beha.2023.101511_bib20","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ng.430","article-title":"Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia","volume":"41","author":"Papaemmanuil","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101511_bib21","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ng.432","article-title":"Germline genomic variants associated with childhood acute lymphoblastic leukemia","volume":"41","author":"Trevi\u00f1o","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101511_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.beha.2023.101511_bib23","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1517\/14656566.8.16.2775","article-title":"A review of the clinical and economic outcomes of imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"8","author":"Carpiuc","year":"2007","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.beha.2023.101511_bib24","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3389\/fonc.2020.01594","article-title":"Chimeric antigen receptor T-cells in B-acute lymphoblastic leukemia: state of the art and future directions","volume":"10","author":"Greenbaum","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.beha.2023.101511_bib25","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric acute lymphoblastic leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101511_bib26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1200\/JCO.2016.70.7836","article-title":"Genetic basis of acute lymphoblastic leukemia","volume":"35","author":"Iacobucci","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2023.101511_bib27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3892\/ol.2020.11583","article-title":"Pathogenesis of pediatric B-cell acute lymphoblastic leukemia: molecular pathways and disease treatments","volume":"20","author":"Huang","year":"2020","journal-title":"Oncol Lett"},{"key":"10.1016\/j.beha.2023.101511_bib28","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.74.3617","article-title":"IKZF1plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric B-cell precursor acute lymphoblastic leukemia","volume":"36","author":"Stanulla","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2023.101511_bib29","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2014-03-562918","article-title":"A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia","volume":"124","author":"Moorman","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/ng.3301","article-title":"The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia","volume":"47","author":"Paulsson","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101511_bib31","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/leu.2015.107","article-title":"KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia","volume":"29","author":"Malinowska-Ozdowy","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101511_bib32","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1182\/blood-2015-09-671131","article-title":"Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levels","volume":"126","author":"Mullighan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/ng.2532","article-title":"The genomic landscape of hypodiploid acute lymphoblastic leukemia","volume":"45","author":"Holmfeldt","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101511_bib34","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2016-10-743765","article-title":"Near-haploid and low-hypodiploid acute lymphoblastic leukemia: two distinct subtypes with consistently poor prognosis","volume":"129","author":"Safavi","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.cancergen.2019.07.009","article-title":"Masked hypodiploidy: hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: a report from the Children's Oncology Group","volume":"238","author":"Carroll","year":"2019","journal-title":"Cancer Genet."},{"key":"10.1016\/j.beha.2023.101511_bib36","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1200\/JCO.2013.48.9377","article-title":"Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97\/99 and UKALL2003 trials","volume":"31","author":"Moorman","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2023.101511_bib37","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood-2014-08-569228","article-title":"Blood Spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease","volume":"125","author":"Harrison","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/gcc.20412","article-title":"Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle","volume":"46","author":"Robinson","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.beha.2023.101511_bib39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature13115","article-title":"Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia","volume":"508","author":"Li","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.beha.2023.101511_bib40","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1073\/pnas.95.8.4584","article-title":"Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia","volume":"95","author":"Ford","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2023.101511_bib41","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1182\/blood.V94.3.1057.415k10_1057_1062","article-title":"Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero","volume":"94","author":"Wiemels","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib42","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/leu.2014.322","article-title":"Clonal origins of ETV6-RUNX1+ acute lymphoblastic leukemia: studies in monozygotic twins","volume":"29","author":"Alpar","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101511_bib43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature21076","article-title":"Metabolic gatekeeper function of B-lymphoid transcription factors","volume":"542","author":"Chan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.beha.2023.101511_bib44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ng.2874","article-title":"RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia","volume":"46","author":"Papaemmanuil","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101511_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms11790","article-title":"Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia","volume":"7","author":"Lilljebj\u00f6rn","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2023.101511_bib46","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3324\/haematol.2021.280146","article-title":"Outstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial","volume":"107","author":"Guest","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101511_bib47","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","article-title":"A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial","volume":"370","author":"Pieters","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.beha.2023.101511_bib48","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2214171","article-title":"Blinatumomab added to chemotherapy in infant lymphoblastic leukemia","author":"van der Sluis","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2023.101511_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2017.213","article-title":"The MLL recombinome of acute leukemias in 2017","volume":"32","author":"Meyer","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101511_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201400449","article-title":"MLL leukemia and future treatment strategies","volume":"348","author":"Marschalek","year":"2015","journal-title":"Arch Pharm"},{"key":"10.1016\/j.beha.2023.101511_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2017.00004","article-title":"MLL-rearranged leukemias-an update on science and clinical approaches","volume":"5","author":"Winters","year":"2017","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.beha.2023.101511_bib52","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.3362","article-title":"Genomics and drug profiling of fatal TCF3-HLF\u2212positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options","volume":"47","author":"Fischer","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101511_bib53","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1182\/blood-2012-10-462358","article-title":"Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL","volume":"122","author":"van der Veer","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib54","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1200\/JCO.2014.55.4105","article-title":"Outcomes of children with BCR-ABL1\u2013like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease","volume":"32","author":"Roberts","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.beha.2023.101511_bib55","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2018-04-841676","article-title":"Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group","volume":"132","author":"Roberts","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib56","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3324\/haematol.2017.186320","article-title":"Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion","volume":"104","author":"Ohki","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101511_bib57","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41375-022-01737-4","article-title":"Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group","volume":"37","author":"Ohki","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101511_bib58","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3324\/haematol.2018.204487","article-title":"ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity","volume":"104","author":"Zaliova","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101511_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/ng.3691","article-title":"Deregulation of DUX4 and ERG in acute lymphoblastic leukemia","volume":"48","author":"Zhang","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101511_bib60","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101511_bib61","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib62","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3324\/haematol.2016.151035","article-title":"ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype","volume":"102","author":"Hirabayashi","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101511_bib63","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2018.206961","article-title":"NUTM1 is a recurrent fusion gene partner in B-cell precursor acute lymphoblastic leukemia associated with increased expression of genes on chromosome band 10p12.31-12.2","volume":"104","author":"Hormann","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101511_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-021-01333-y","article-title":"Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study","volume":"35","author":"Boer","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101511_bib65","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.2021014723","article-title":"Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL","volume":"139","author":"Passet","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib66","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1182\/blood.2022015444","article-title":"Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia","volume":"139","author":"Kimura","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib67","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1038\/s41375-022-01557-6","article-title":"UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment","volume":"36","author":"Bastian","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101511_bib68","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/bjh.17002","article-title":"High-risk B-cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse","volume":"191","author":"McClure","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2023.101511_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01374","article-title":"B-ALL with t(5;14)(q31;q32); IGH-IL3 rearrangement and eosinophilia: a comprehensive analysis of a peculiar IGH-rearranged B-all","volume":"9","author":"Fournier","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.beha.2023.101511_bib70","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3324\/haematol.2021.280557","article-title":"Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement","volume":"108","author":"Bomken","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101511_bib71","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101511_bib72","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrc.2016.63","article-title":"The genetics and mechanisms of T cell acute lymphoblastic leukaemia","volume":"16","author":"Belver","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.beha.2023.101511_bib73","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","article-title":"The genetics and molecular biology of T-ALL","volume":"129","author":"Girardi","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib74","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/blood.2019001880","article-title":"The whole-genome landscape of Burkitt lymphoma subtypes","volume":"134","author":"Panea","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib75","first-page":"61","article-title":"Treatment of pediatric acute lymphoblastic leukemia","volume":"62","author":"Stacy","year":"2015","journal-title":"Pediatr Clin"},{"key":"10.1016\/j.beha.2023.101511_bib76","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1158\/0008-5472.BCD-19-0041","article-title":"Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia","volume":"1","author":"Waanders","year":"2020","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.beha.2023.101511_bib77","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1038\/ncomms7604","article-title":"Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia","volume":"6","author":"Ma","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.beha.2023.101511_bib78","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V116.21.413.413","article-title":"CREBBP mutations in relapsed acute lymphoblastic leukemia","volume":"116","author":"Mullighan","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib79","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/leu.2010.87","article-title":"IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL","volume":"24","author":"Kuiper","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101511_bib80","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2020.259226","article-title":"Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations","author":"Anti\u0107","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.beha.2023.101511_bib81","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2023.101511_bib82","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.1164266","article-title":"Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia","volume":"322","author":"Mullighan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.beha.2023.101511_bib83","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/ng.2777","article-title":"Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia","volume":"45","author":"Jaffe","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101511_bib84","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/ng.2558","article-title":"Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia","volume":"45","author":"Meyer","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101511_bib85","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1182\/blood.2019002220","article-title":"Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia","volume":"135","author":"Li","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.beha.2023.101511_bib86","first-page":"819","article-title":"Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse","volume":"2","author":"Yang","year":"2021","journal-title":"Nat Can (Ott)"},{"key":"10.1016\/j.beha.2023.101511_bib87","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41571-018-0136-6","article-title":"Somatic and germline genomics in paediatric acute lymphoblastic leukaemia","volume":"16","author":"Pui","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.beha.2023.101511_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/bjc.1991.216","article-title":"An estimate of the heritable fraction of childhood cancer","volume":"63","author":"Narod","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beha.2023.101511_bib89","doi-asserted-by":"crossref","DOI":"10.1080\/17474086.2020.1685866","article-title":"Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia","volume":"13","author":"Bloom","year":"2020","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.beha.2023.101511_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2007.04.004","article-title":"Trisomy of chromosome 21 in leukemogenesis","volume":"39","author":"Izraeli","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.beha.2023.101511_bib91","article-title":"Hematologic malignancies and Li-Fraumeni syndrome","volume":"5","author":"Swaminathan","year":"2019","journal-title":"Cold Spring Harbor Mole. Case Stud."},{"key":"10.1016\/j.beha.2023.101511_bib92","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026286","article-title":"TP53 mutations in hypodiploid acute lymphoblastic leukemia","volume":"7","author":"Comeaux","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.beha.2023.101511_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(15)00369-1","article-title":"Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study","volume":"16","author":"Moriyama","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beha.2023.101511_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.38142","article-title":"Childhood cancer predisposition syndromes-A concise review and recommendations by the cancer predisposition working group of the society for pediatric oncology and hematology","volume":"173","author":"Ripperger","year":"2017","journal-title":"Am J Med Genet"},{"issue":"10","key":"10.1016\/j.beha.2023.101511_bib95","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1182\/bloodadvances.2022008563","article-title":"Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia","volume":"7","author":"Escherich","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.beha.2023.101511_bib96","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2016.277","article-title":"Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences","volume":"31","author":"Waanders","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101511_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/nature25480","article-title":"The landscape of genomic alterations across childhood cancers","volume":"555","author":"Gr\u00f6bner","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.beha.2023.101511_bib98","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s41375-021-01163-y","article-title":"Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li\u2013Fraumeni syndrome","volume":"35","author":"Winter","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101511_bib99","doi-asserted-by":"crossref","first-page":"l1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.beha.2023.101511_bib100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.beha.2023.101511_bib101","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.3390\/cancers13225653","article-title":"Transcriptional and mutational profiling of B-other acute lymphoblastic leukemia for improved diagnostics","volume":"13","author":"Chouvarine","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.beha.2023.101511_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.26487","article-title":"Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping","volume":"97","author":"Rack","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beha.2023.101511_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174388","article-title":"The clinical utility of optical genome mapping for the assessment of genomic aberrations in acute lymphoblastic leukemia","volume":"13","author":"L\u00fchmann","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.beha.2023.101511_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41588-022-01159-z","article-title":"The genomic landscape of pediatric acute lymphoblastic leukemia","volume":"54","author":"Brady","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2023.101511_bib105","first-page":"1","article-title":"Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia","author":"Ryan","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.beha.2023.101511_bib106","unstructured":"What is long read sequencing? PHG Foundation n.d. https:\/\/www.phgfoundation.org\/briefing\/what-is-long-read-sequencing (accessed March 6, 2023)."},{"key":"10.1016\/j.beha.2023.101511_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2019.100780","article-title":"Scalable prediction of acute myeloid leukemia using high-dimensional machine learning and blood transcriptomics","volume":"23","author":"Warnat-Herresthal","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.beha.2023.101511_bib108","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2021005894","article-title":"ALLSorts: an RNA-Seq subtype classifier for B-cell acute lymphoblastic leukemia","volume":"6","author":"Schmidt","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.beha.2023.101511_bib109","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03922-4","article-title":"Biologically informed deep neural network for prostate cancer discovery","volume":"598","author":"Elmarakeby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.beha.2023.101511_bib110","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12859-018-2500-z","article-title":"PASNet: pathway-associated sparse deep neural network for prognosis prediction from high-throughput data","volume":"19","author":"Hao","year":"2018","journal-title":"BMC Bioinf"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692623000725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692623000725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:08:17Z","timestamp":1761498497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692623000725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1521692623000725"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2023.101511","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenetics and genomics in pediatric acute lymphoblastic leukaemia","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2023.101511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101511"}}